Bauerschmitz GJ - Search Results

1

Adenoviral gene therapy for cancer: from vectors to targeted and replication competent agents (review).

Bauerschmitz GJ, Barker SD, Hemminki A. Bauerschmitz GJ, et al. Int J Oncol. 2002 Dec;21(6):1161-74. Int J Oncol. 2002. PMID: 12429964 Review.

2

Transductional and transcriptional targeting of adenovirus for clinical applications.

Glasgow JN, Bauerschmitz GJ, Curiel DT, Hemminki A. Glasgow JN, et al. Among authors: bauerschmitz gj. Curr Gene Ther. 2004 Mar;4(1):1-14. doi: 10.2174/1566523044577997. Curr Gene Ther. 2004. PMID: 15032610 Review.

3

Treatment of ovarian cancer with a tropism modified oncolytic adenovirus.

Bauerschmitz GJ, Lam JT, Kanerva A, Suzuki K, Nettelbeck DM, Dmitriev I, Krasnykh V, Mikheeva GV, Barnes MN, Alvarez RD, Dall P, Alemany R, Curiel DT, Hemminki A. Bauerschmitz GJ, et al. Cancer Res. 2002 Mar 1;62(5):1266-70. Cancer Res. 2002. PMID: 11888888

4

Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses.

Kanerva A, Wang M, Bauerschmitz GJ, Lam JT, Desmond RA, Bhoola SM, Barnes MN, Alvarez RD, Siegal GP, Curiel DT, Hemminki A. Kanerva A, et al. Among authors: bauerschmitz gj. Mol Ther. 2002 Jun;5(6):695-704. doi: 10.1006/mthe.2002.0599. Mol Ther. 2002. PMID: 12027553 Free article.

5

Replication of an integrin targeted conditionally replicating adenovirus on primary ovarian cancer spheroids.

Lam JT, Bauerschmitz GJ, Kanerva A, Barker SD, Straughn JM, Wang M, Barnes MN, Blackwell JL, Siegal GP, Alvarez RD, Curiel DT, Hemminki A. Lam JT, et al. Among authors: bauerschmitz gj. Cancer Gene Ther. 2003 May;10(5):377-87. doi: 10.1038/sj.cgt.7700578. Cancer Gene Ther. 2003. PMID: 12719707

6

Evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancer.

Bauerschmitz GJ, Kanerva A, Wang M, Herrmann I, Shaw DR, Strong TV, Desmond R, Rein DT, Dall P, Curiel DT, Hemminki A. Bauerschmitz GJ, et al. Int J Cancer. 2004 Aug 20;111(2):303-9. doi: 10.1002/ijc.20217. Int J Cancer. 2004. PMID: 15197787 Free article.

7

Inter-patient variation in efficacy of five oncolytic adenovirus candidates for ovarian cancer therapy.

Lam JT, Kanerva A, Bauerschmitz GJ, Takayama K, Suzuki K, Yamamoto M, Bhoola SM, Liu B, Wang M, Barnes MN, Alvarez RD, Siegal GP, Curiel DT, Hemminki A. Lam JT, et al. Among authors: bauerschmitz gj. J Gene Med. 2004 Dec;6(12):1333-42. doi: 10.1002/jgm.635. J Gene Med. 2004. PMID: 15493039

8

Triple-targeted oncolytic adenoviruses featuring the cox2 promoter, E1A transcomplementation, and serotype chimerism for enhanced selectivity for ovarian cancer cells.

Bauerschmitz GJ, Guse K, Kanerva A, Menzel A, Herrmann I, Desmond RA, Yamamoto M, Nettelbeck DM, Hakkarainen T, Dall P, Curiel DT, Hemminki A. Bauerschmitz GJ, et al. Mol Ther. 2006 Aug;14(2):164-74. doi: 10.1016/j.ymthe.2006.01.010. Epub 2006 Mar 31. Mol Ther. 2006. PMID: 16580264 Free article.

9

Oncolytic adenovirus based on serotype 3.

Hemminki O, Bauerschmitz G, Hemmi S, Lavilla-Alonso S, Diaconu I, Guse K, Koski A, Desmond RA, Lappalainen M, Kanerva A, Cerullo V, Pesonen S, Hemminki A. Hemminki O, et al. Cancer Gene Ther. 2011 Apr;18(4):288-96. doi: 10.1038/cgt.2010.79. Epub 2010 Dec 24. Cancer Gene Ther. 2011. PMID: 21183947 Free article.

10

Luciferase imaging for evaluation of oncolytic adenovirus replication in vivo.

Guse K, Dias JD, Bauerschmitz GJ, Hakkarainen T, Aavik E, Ranki T, Pisto T, Särkioja M, Desmond RA, Kanerva A, Hemminki A. Guse K, et al. Among authors: bauerschmitz gj. Gene Ther. 2007 Jun;14(11):902-11. doi: 10.1038/sj.gt.3302949. Epub 2007 Mar 22. Gene Ther. 2007. PMID: 17377596

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

50 results

Search Page